Paper34811367
A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems.
Packer M and 4 others. Nat Commun, 2021. Cited by 211 papers, by iCite.
Cite this record
ConductScience Library. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Papers, record 34811367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34811367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Liposomes | Major topic |
| Nanoparticles | Major topic |
| RNA, Messenger | Major topic |
| Vaccine Potency | Major topic |
| Aldehydes | |
| Chromatography, Liquid | |
| Humans | |
| Ions | |
| Lipids | |
| Nucleosides | |
| Oxidation-Reduction | |
| Protein Biosynthesis | |
| RNA Stability | |
| mRNA Vaccines |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11139637 | RNA analysis by ion-pair reversed-phase high performance liquid chromatography. | Nucleic Acids Res | 2001 | https://conductscience.org/library/papers/11139637 | PubMed |
| 2 | 32093140 | Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32093140 | PubMed |
| 3 | 23792630 | Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23792630 | PubMed |
| 4 | 33321139 | Addressing the Cold Reality of mRNA Vaccine Stability. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/33321139 | PubMed |
| 5 | 33378609 | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33378609 | PubMed |
| 6 | 29323295 | Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. | Nature | 2018 | https://conductscience.org/library/papers/29323295 | PubMed |
| 7 | 10737906 | Chemical stability of nucleic acid-derived drugs. | J Pharm Sci | 2000 | https://conductscience.org/library/papers/10737906 | PubMed |
| 8 | 30705318 | HPLC methods for purity evaluation of man-made single-stranded RNAs. | Sci Rep | 2019 | https://conductscience.org/library/papers/30705318 | PubMed |
| 9 | 30846391 | Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. | Mol Ther | 2019 | https://conductscience.org/library/papers/30846391 | PubMed |
| 10 | 33660201 | Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives. | Pharm Res | 2021 | https://conductscience.org/library/papers/33660201 | PubMed |
| 11 | 32637598 | Impact of mRNA chemistry and manufacturing process on innate immune activation. | Sci Adv | 2020 | https://conductscience.org/library/papers/32637598 | PubMed |
| 12 | 19239894 | The many pathways of RNA degradation. | Cell | 2009 | https://conductscience.org/library/papers/19239894 | PubMed |
| 13 | 33301246 | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. | N Engl J Med | 2020 | https://conductscience.org/library/papers/33301246 | PubMed |
| 14 | 33295773 | Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge. | Mol Pharm | 2021 | https://conductscience.org/library/papers/33295773 | PubMed |
| 15 | 8746443 | Factors affecting DNA damage caused by lipid hydroperoxides and aldehydes. | Free Radic Biol Med | 1996 | https://conductscience.org/library/papers/8746443 | PubMed |
| 16 | 20584607 | N-demethylation of N-methyl alkaloids with ferrocene. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20584607 | PubMed |
| 17 | 33815564 | Role of nanotechnology behind the success of mRNA vaccines for COVID-19. | Nano Today | 2021 | https://conductscience.org/library/papers/33815564 | PubMed |
| 18 | 26889757 | Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery. | Adv Mater | 2016 | https://conductscience.org/library/papers/26889757 | PubMed |
| 19 | 29433939 | Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency. | Mol Ther | 2018 | https://conductscience.org/library/papers/29433939 | PubMed |
| 20 | 33195094 | Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy. | Front Chem | 2020 | https://conductscience.org/library/papers/33195094 | PubMed |
Cited by127
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42975285 | Poly(acrylamido) PEG-Alternative Lipids Rescue mRNA Efficacy during Repeated Dosing and Enhance Immune Cell Delivery. | ACS Nano | 2026 | https://conductscience.org/library/papers/42975285 | PubMed |
| 42916086 | Boosting Ligand-Mediated Hepatic mRNA Delivery and Gene Editing Through Coordinated Pairing of Polyethylene Glycol-Modified Lipids. | ACS Nano | 2026 | https://conductscience.org/library/papers/42916086 | PubMed |
| 42908836 | pSIM: A next generation in vitro mRNA potency assay. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42908836 | PubMed |
| 42806112 | Accelerated discovery of thermostable mRNA-lipid nanoparticle vaccines using data-efficient AI. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42806112 | PubMed |
| 42791758 | Preparation of Targeted Delivery Materials and Their Application in Animal Production. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42791758 | PubMed |
| 42764981 | Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42764981 | PubMed |
| 42683374 | Amine oxide lipid nanoparticles for delivery of cyclic dinucleotides. | Natl Sci Rev | 2026 | https://conductscience.org/library/papers/42683374 | PubMed |
| 42653382 | Critical Evaluation of Key Methods for RNA Quantification. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653382 | PubMed |
| 42627629 | Comprehensive Analytical Characterization of mRNA Influenza Vaccine Under Stress Conditions: Implications for Stability and Quality Control. | Pharm Res | 2026 | https://conductscience.org/library/papers/42627629 | PubMed |
| 42593721 | Critical chemistry manufacturing and controls considerations for mRNA lipid nanoparticle translation. | Discov Nano | 2026 | https://conductscience.org/library/papers/42593721 | PubMed |
| 42539106 | Post-loading ribonucleic acid into lipid nanoparticle carriers. | bioRxiv | 2026 | https://conductscience.org/library/papers/42539106 | PubMed |
| 42523296 | Peptide additives reprogram the lipid nanoparticle corona and enhance gene delivery in a serum-free environment for lung epithelium. | bioRxiv | 2026 | https://conductscience.org/library/papers/42523296 | PubMed |
| 42514871 | Analytical Characterization and Stability Assessment of RNA-Based Vaccines. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514871 | PubMed |
| 42506657 | Possible Mechanisms of mRNA-LNP Degradation: A Comprehensive Review. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42506657 | PubMed |
| 42441759 | Ligand-Mediated Reprogramming Redirects Liver-Tropic Ionizable Lipid Nanoparticles for Lung-Selective mRNA Delivery. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42441759 | PubMed |
| 42342874 | Immunological mechanisms of mRNA vaccines for infectious diseases. | Nature | 2026 | https://conductscience.org/library/papers/42342874 | PubMed |
| 42283697 | Storage Buffer Composition Impacts Internal Structure, Freeze-Thaw Stability, and Transfection Efficiency of mRNA-Lipid Nanoparticles. | ACS Nano | 2026 | https://conductscience.org/library/papers/42283697 | PubMed |
| 42243120 | Antioxidant lipid nanoparticles enhance mRNA stability for regeneration therapy and gene editing. | Nat Commun | 2026 | https://conductscience.org/library/papers/42243120 | PubMed |
| 42198337 | Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198337 | PubMed |
| 42198221 | Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198221 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34811367
GET https://conductscience.org/api/papers/v1/34811367/references?page=2